Wall Street sell-side analysts are projecting Heron Therapeutics, Inc. (NASDAQ:HRTX) to grow at an accelerated rate over the next 5 years. Brokerage firms are looking for the firm to grow 30.10% over the next year and 34.85% over the next five years.
Heron Therapeutics, Inc.’s trailing 12- months EPS is -3.79. Last year, their EPS growth was -54.80% and their EPS growth over the past five years was -19.10%.
Let’s start off by taking a look at how the stock has been performing recently. Over the past twelve months, Heron Therapeutics, Inc. (NASDAQ:HRTX)’s stock was 30.92%. Last week, it was 0.59%, 6.52% over the last quarter, and 22.06% for the past half-year.
Over the past 50 days, Heron Therapeutics, Inc. stock was -16.03% off of the high and 7.29% removed from the low. Their 52-Week High and Low are noted here. -16.03% (High), 26.50%, (Low).
Heron Therapeutics, Inc. (NASDAQ:HRTX)’s performance this year to date is 30.92%. The stock has performed 0.59% over the last seven days, 10.65% over the last thirty, and 6.52% over the last three months. Over the last six months, Heron Therapeutics, Inc.’s stock has been 22.06% and 11.73% for the year.
Wall Street analysts are have a consensus analyst recommendation of 1.70 on the stock. This is based on a 1-5 scale where 1 represents a Strong Buy and 5 a Strong Sell. Brokerages covering the name have a $31.00 on the stock.
The advice provided on this website is general advice only. It has been prepared without taking into account your objectives, financial situation or needs. Before acting on this advice you should consider the appropriateness of the advice, having regard to your own objectives, financial situation and needs. Where quoted, past performance is not indicative of future performance.